3 free views remaining today

non-syndromic X-linked intellectual disability 73

Description

Non-syndromic X-linked intellectual disability (NS-XLMR) refers to a condition where males have intellectual disability without any additional physical, neurological, or psychiatric symptoms

Additional Characteristics

  • intellectual disability
  • males
  • physical
  • neurological
  • psychiatric

Signs and Symptoms

Non-syndromic X-linked intellectual disability (NS-XLMR) is a condition characterized by intellectual disability in the absence of other symptoms or signs. The signs and symptoms of NS-XLMR can vary from person to person, but some common features include:

  • Intellectual disability: This is the primary symptom of NS-XLMR, with affected individuals typically having average to below-average intelligence.
  • Weak muscle tone (hypotonia): Many people with NS-XLMR have weak muscle tone, which can delay motor skills such as sitting, standing, and walking [8].
  • Delayed speech development: Some individuals with NS-XLMR may experience delayed or impaired speech development [7].
  • Average head circumference: Affected individuals often have average head circumferences, unlike some other intellectual disability conditions [7].

It's essential to note that not everyone with NS-XLMR will exhibit all of these symptoms, and the severity can vary widely from person to person. Additionally, some individuals may experience additional symptoms or signs, but these are typically not as pronounced as those associated with syndromic X-linked intellectual disabilities.

References: [7] - [8]

Additional Symptoms

  • Intellectual disability
  • Weak muscle tone (hypotonia)
  • Delayed speech development
  • Average head circumference

Diagnostic Tests

Non-syndromic X-linked intellectual disability (NS-XLMR) can be challenging to diagnose, but various diagnostic tests are available to help identify the underlying genetic cause.

  • Chromosomal Microarray Analysis (CMA): This is a first-line genetic test recommended by medical genetics groups for children with intellectual disabilities. CMA can detect deletions or duplications of genetic material on the X-chromosome, which may be associated with NS-XLMR [5].
  • Genetic testing: Specific genetic tests are available to identify mutations in genes known to cause NS-XLMR. These tests can help diagnose the specific type of intellectual disability present and guide treatment.
  • Karyotype analysis: This test examines the number and structure of chromosomes, which can reveal abnormalities associated with NS-XLMR [12].
  • Fragile X syndrome testing: Since Fragile X syndrome is a common cause of NS-XLMR, genetic testing for this condition is often performed as part of the diagnostic workup.

It's essential to note that genetic testing can be complex and may require consultation with a medical genetics specialist. A comprehensive diagnostic approach, including clinical evaluation, family history, and genetic testing, is crucial for accurate diagnosis and management of NS-XLMR [14].

References: [5] - Medical genetics groups recommend chromosomal microarray analysis (CMA) as a first-line genetic test to identify genetic mutations in children with intellectual disabilities. [12] - Karyotype abnormalities can be associated with non-syndromic X-linked intellectual disability. [14] - A comprehensive diagnostic approach, including clinical evaluation, family history, and genetic testing, is crucial for accurate diagnosis and management of NS-XLMR.

Additional Diagnostic Tests

  • Genetic testing
  • Karyotype analysis
  • Fragile X syndrome testing
  • CMA

Treatment

Current Status of Drug Treatment for Non-Syndromic X-Linked Intellectual Disability

Unfortunately, there is no specific pharmacologic treatment available for cognitive impairment in individuals with non-syndromic X-linked intellectual disability (NS-XLID) [8]. However, researchers have identified several genes associated with NS-XLID that may provide potential targets for drug treatment.

Genetic Basis and Potential Targets

Studies have implicated various genes in the development of NS-XLID, including those involved in transcriptional regulation, mitochondrial function, glycoprotein metabolism, and ubiquitination [15]. These findings

Recommended Medications

  • No specific pharmacologic treatment available
  • Potential targets for drug treatment identified

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Non-syndromic X-linked intellectual disability (NS-XLMR) has a complex differential diagnosis, involving various conditions that present with similar symptoms or clinical findings.

Key Differential Diagnoses:

  • Other forms of X-linked ID [4]
  • Börjeson-Forssman-Lehmann syndrome
  • Wilson-Turner syndrome
  • Smith-Fineman-Myers syndrome [6]

These conditions often involve intellectual disability, but may also present with additional symptoms or physical anomalies. A thorough evaluation and genetic testing are necessary to rule out these differential diagnoses.

Other Conditions to Consider:

  • Fragile X syndrome (FMR1 gene)
  • Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome [13]
  • Intellectual developmental disorders without other distinctive findings [14]

These conditions may also present with intellectual disability, and a comprehensive evaluation is necessary to determine the underlying cause.

Prevalence of NS-XLMR:

The prevalence of non-syndromic X-linked intellectual disability (NS-XLMR) is estimated to be around 1-2% in selected research samples [11]. However, this figure may vary depending on the population being studied and the specific genes involved.

Genetic Testing:

Systematic screening of all other X-linked genes in X-linked families with mental retardation is currently not feasible in a clinical setting [15]. Therefore, genetic testing should be focused on identifying the specific gene responsible for the NS-XLMR in each family.

References:

[4] - Non-syndromic XLID is characterized by intellectual disability in the absence of other symptoms... Other differential diagnoses include other forms of X-linked ID... [6] - Differential diagnosis. Differential diagnosis includes Börjeson-Forssman-Lehmann syndrome, Wilson-Turner syndrome and Smith-Fineman-Myers syndrome. [11] - The prevalence of Fragile X syndrome in affected sib pairs and X linked families is approximately 12/45 (27%), although this figure predates molecular genetic analysis and is likely to be an overestimate. [13] - Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). [14] - An intellectual disability multigene panel that includes TRIO and other... all intellectual developmental disorders without other distinctive findings should be considered in the differential diagnosis. [15] - Mental retardation is more common in males than females in the population, assumed to be due to mutations on the X chromosome. The prevalence of the 24 genes identified to date is low and less common than expansions in FMR1, which cause Fragile X syndrome.

Additional Differential Diagnoses

  • Other forms of X-linked ID
  • Fragile X syndrome (FMR1 gene)
  • Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome
  • Intellectual developmental disorders without other distinctive findings
  • N syndrome
  • Wilson-Turner syndrome

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6527
owl#annotatedSource
t384093
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0112017
core#notation
DOID:0112017
oboInOwl#hasDbXref
MIM:300355
IAO_0000115
A non-syndromic X-linked intellectual disability characterized by mild to moderate intellectual disability in males that has_material_basis_in hemizygous mutation in a region on chromosome Xp22.2.
oboInOwl#hasExactSynonym
X-linked mental retardation 73
rdf-schema#label
non-syndromic X-linked intellectual disability 73
rdf-schema#subClassOf
t384377
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.